GPT and fatty liver disease: Results of repeated measures ANOVAs examining health markers at the initial visits vs. follow ups indicated there were statistically significant improvements in ALT and AST liver enzyme levels (i.e., markers of fatty liver disease) between initial visits and follow ups within the multidisciplinary T2D clinic, (ALT: F = 13.43, p < .001; AST: F = 6.58, p < .05) with ALT: M = 53.8, SE = 6.7; AST: M = 34.9, SE = 3.8 at the initial visit to ALT: M = 39.4, SE = 4.66; AST: M = 28.3, SE = 2.59 at follow-up).